Multidrug resistance: Physiological principles and nanomedical solutions.
about
Multidrug resistance: an emerging crisisNANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Nanotechnology in the war against cancer: new arms against an old enemy - a clinical view.The Theranostic Path to Personalized NanomedicineIn vivo imaging of multidrug resistance using a third generation MDR1 inhibitor.Vinblastine as a second rescue for the treatment of canine multicentric lymphoma in 39 cases (2005 to 2014).Targeting cellular and microenvironmental multidrug resistance.Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.Improving In Vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems.TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathwayPluronics and MDR reversal: an update.Expression of multidrug resistance-associated proteins and their relation to postoperative individualized chemotherapy in gastric cancer.Self-assembled nanoscale coordination polymers carrying siRNAs and cisplatin for effective treatment of resistant ovarian cancer.Significance of multidrug resistance gene-related proteins in the postoperative chemotherapy of gastric cancerImmunomodulatory Protein from Ganoderma microsporum Induces Pro-Death Autophagy through Akt-mTOR-p70S6K Pathway Inhibition in Multidrug Resistant Lung Cancer Cells.Comparison of cytotoxicity between extracts of Clinacanthus nutans (Burm. f.) Lindau leaves from different locations and the induction of apoptosis by the crude methanol leaf extract in D24 human melanoma cells.Dual subcellular compartment delivery of doxorubicin to overcome drug resistant and enhance antitumor activity.POLYMERIC BIOMATERIALS AND NANOMEDICINES.ATP-binding cassette transporters in reproduction: a new frontier.Ferrocenyl 2,5-Piperazinediones as Tubulin-Binding Organometallic ABCB1 and ABCG2 Inhibitors Active against MDR Cells.N-alkylated isatins evade P-gp mediated efflux and retain potency in MDR cancer cell linesDoxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance.Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells.The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy.Review of natural compounds for potential skin cancer treatment.The Use of Anthracyclines for Therapy of CNS Tumors.Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer.Responses of human hepatoma HepG2 cells to silver nanoparticles and polycyclic aromatic hydrocarbons.Overcoming multidrug resistance using folate receptor-targeted and pH-responsive polymeric nanogels containing covalently entrapped doxorubicin.PLGA nanoparticles as a platform for vitamin D-based cancer therapyNano-based strategies to overcome p-glycoprotein-mediated drug resistance.Controlled and Targeted Drug Delivery by a UV-responsive Liposome for Overcoming Chemo-resistance in Non-Hodgkin Lymphoma.Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance.Theranostic nanoemulsions: codelivery of hydrophobic drug and hydrophilic imaging probe for cancer therapy and imaging.Anticancer Properties of Solamargine: A Systematic Review.Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo.Unique spectral markers discern recurrent Glioblastoma cells from heterogeneous parent population.ATP7B expression confers multidrug resistance through drug sequestrationStructural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells.pH-sensitive and folic acid-targeted MPEG-PHIS/FA-PEG-VE mixed micelles for the delivery of PTX-VE and their antitumor activity.
P2860
Q21284693-80FD2C77-FCBB-4BE2-8DDA-C4ACE42BDEE5Q28078448-839A042E-4442-4F03-B9A1-C93E3DB4B7B5Q30376531-820E848D-6768-4335-8705-4EF6D1B88D2FQ30437998-342AEC49-FF61-4D9F-8F06-9D2FE1E9A53EQ30583710-688D97DA-A8A1-440D-A255-8AC59A5C9BE8Q33432667-B011DFB6-C242-40B9-AA0B-3FDBE449A4A2Q33602284-9860702D-6E23-45C5-8100-93A3031571DEQ33634653-8EB8125A-748E-4CCF-80CE-762AB40F69A1Q33710442-5B62E79B-3010-4E49-9624-9C34B1E8F149Q33784625-D8C45473-2304-4DC9-9C48-7F6853F381B7Q34005678-586263F0-435E-4590-8FA5-253134578CB2Q34346821-3640D257-F440-43F0-AE5F-F14B75CB96C5Q34617008-C8CC4BD0-B441-4423-8D7B-AC7023EC9841Q34733148-92F88D4C-744D-42C4-8C68-1CB964F5337EQ35577645-6F00CEC5-618B-489A-9180-94FEDDF122ABQ36137750-EDDDBC12-7D60-4A4E-8BDD-CAE0E7B10381Q36245928-73B12654-39DB-4DD4-A83D-AA4FFD1D1D58Q36376467-11AAA97F-6CE5-4D31-A6F7-D41DD674CCEBQ36585155-0489A042-A8FD-4C40-9558-4035B7CDAACDQ36996281-C598294B-2174-4185-A9D1-F52561DAF472Q37096409-CEF35362-CD9B-4988-8EC6-7C2CFAD6FC27Q37330473-CF5BDC23-0C20-47E9-A3DB-3EE0E38DA564Q37573748-B5AA10EF-A1FE-4C5B-8E74-190BD3337457Q37576360-008CD069-B3AE-4671-9652-1A3CC6506F2FQ38237757-70C24F44-5C8B-43B3-BD8A-4B865B926FCCQ38407992-7470242D-FC52-403E-9FBC-3A68B3421E96Q38637648-5DE81C61-CDAC-437F-B81A-7BCEE5D1B36BQ38672832-BF3A3A1F-A99C-4458-B05D-5343246A1330Q38681692-73E78BD6-EEF0-4C75-AE85-07DA8D675EC9Q38850543-34732E12-D4A3-4985-8899-0801ACF0241CQ38856533-BD2D7DE4-40C8-4E47-9A8C-277CED0EA463Q38903528-A3CA3331-88C9-4E16-8E4E-DC8DE08FCF0FQ38924917-B7D8DD88-0406-4BF6-BB21-70A369908443Q38977484-2B229DE4-43B9-4C7C-9916-DF164FD530CEQ39223958-BD137FE4-6EBC-40A7-AC2A-6CD9E9BE70E1Q39485731-B70C11A6-4509-4D0A-8AEF-F72BA8FE022FQ39738921-A3BB75C7-831B-4B44-8D26-4365C94E54BAQ40997062-4AA8073C-2559-4238-A843-CEB38D012265Q41472858-5444BD9A-70A4-48CF-99DF-A9C99302D7C5Q41483792-7A220F5A-913B-4C3B-86B9-4827AC9B1565
P2860
Multidrug resistance: Physiological principles and nanomedical solutions.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Multidrug resistance: Physiological principles and nanomedical solutions.
@en
type
label
Multidrug resistance: Physiological principles and nanomedical solutions.
@en
prefLabel
Multidrug resistance: Physiological principles and nanomedical solutions.
@en
P2860
P50
P1476
Multidrug resistance: Physiological principles and nanomedical solutions
@en
P2093
Fabian Kiessling
Gert Storm
P2860
P304
P356
10.1016/J.ADDR.2013.09.018
P407
P577
2013-10-10T00:00:00Z